B. Cipolla

859 total citations
43 papers, 668 citations indexed

About

B. Cipolla is a scholar working on Molecular Biology, Biochemistry and Surgery. According to data from OpenAlex, B. Cipolla has authored 43 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Biochemistry and 11 papers in Surgery. Recurrent topics in B. Cipolla's work include Polyamine Metabolism and Applications (19 papers), Amino Acid Enzymes and Metabolism (12 papers) and Cannabis and Cannabinoid Research (9 papers). B. Cipolla is often cited by papers focused on Polyamine Metabolism and Applications (19 papers), Amino Acid Enzymes and Metabolism (12 papers) and Cannabis and Cannabinoid Research (9 papers). B. Cipolla collaborates with scholars based in France, Italy and Canada. B. Cipolla's co-authors include R Havouis, J P Moulinoux, F. Guillé, Bernard Lobel, F. Staerman, L. Corbel, Jacques-Philippe Moulinoux, V. Quémener, Moshe Shalev and Yannick Blanchard and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

B. Cipolla

41 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Cipolla France 14 444 150 137 114 101 43 668
Kuo-Feng Hua Taiwan 13 397 0.9× 48 0.3× 53 0.4× 49 0.4× 34 0.3× 15 613
William F. Henry United States 7 191 0.4× 22 0.1× 23 0.2× 31 0.3× 74 0.7× 11 519
Mitsuo Yamazaki Japan 14 221 0.5× 234 1.6× 50 0.4× 170 1.5× 75 0.7× 57 667
D. Tim Harwood New Zealand 14 234 0.5× 26 0.2× 39 0.3× 65 0.6× 98 1.0× 14 647
Molly M. Gilligan United States 7 216 0.5× 35 0.2× 176 1.3× 67 0.6× 56 0.6× 11 705
Weifeng Hu China 12 181 0.4× 48 0.3× 9 0.1× 25 0.2× 32 0.3× 30 445
Ruimin Wang China 13 151 0.3× 41 0.3× 7 0.1× 47 0.4× 41 0.4× 49 503
Yaser Rayyan Jordan 12 99 0.2× 66 0.4× 66 0.5× 91 0.8× 19 0.2× 41 430
Juan José Moreno Spain 9 101 0.2× 63 0.4× 38 0.3× 98 0.9× 29 0.3× 15 584

Countries citing papers authored by B. Cipolla

Since Specialization
Citations

This map shows the geographic impact of B. Cipolla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Cipolla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Cipolla more than expected).

Fields of papers citing papers by B. Cipolla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Cipolla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Cipolla. The network helps show where B. Cipolla may publish in the future.

Co-authorship network of co-authors of B. Cipolla

This figure shows the co-authorship network connecting the top 25 collaborators of B. Cipolla. A scholar is included among the top collaborators of B. Cipolla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Cipolla. B. Cipolla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cipolla, B., E. Mandron, Jean Lefort, et al.. (2015). Effect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy. Cancer Prevention Research. 8(8). 712–719. 96 indexed citations
2.
Cipolla, B., Nicolas Mottet, & Théo Efstathiou. (2014). MP70-08 WITHDRAWN: FIRST DOUBLE-BLIND PLACEBO CONTROLLED, MULTI-CENTRE, RANDOMIZED TRIAL OF SULFORAPHANE IN MEN WITH RISING PSA FOLLOWING RADICAL PROSTATECTOMY. The Journal of Urology. 191(4S). 1 indexed citations
3.
Cipolla, B., E. Mandron, Jean Lefort, et al.. (2014). First double-blind placebo-controlled, multicenter, randomized trial of stabilized natural sulforaphane in men with rising PSA following radical prostatectomy.. Journal of Clinical Oncology. 32(15_suppl). 5032–5032. 4 indexed citations
4.
Cipolla, B., et al.. (2012). Combination of a polyamine-free oral nutritional supplement (ONS) with docetaxel in castrate-resistant prostate cancer (CRPC) patients (pts): A phase II trial.. Journal of Clinical Oncology. 30(15_suppl). e15131–e15131. 2 indexed citations
5.
Cipolla, B., R Havouis, & Jacques-Philippe Moulinoux. (2010). Polyamine reduced diet (PRD) nutrition therapy in hormone refractory prostate cancer patients. Biomedicine & Pharmacotherapy. 64(5). 363–368. 37 indexed citations
6.
Cipolla, B., R Havouis, & Jacques-Philippe Moulinoux. (2010). Cipolla BG, Havouis R, Moulinoux JPPolyamine reduced diet (PRD) nutrition therapy in hormone refractory prostate cancer patients. Biomed Pharmacother 64(5): 363-368. 3 indexed citations
7.
Lughezzani, Giovanni, Pierre I. Karakiewicz, Pierre Bigot, et al.. (2010). The prognostic value of erythrocyte polyamines in the preoperative evaluation of patients with renal cell carcinoma. European Journal of Cancer. 46(10). 1927–1935. 2 indexed citations
8.
Bigot, Pierre, Giovanni Lughezzani, Pierre I. Karakiewicz, et al.. (2009). The Prognostic Value of Erythrocyte Polyamine in the Post-Nephrectomy Stratification of Renal Cell Carcinoma Specific Mortality. The Journal of Urology. 183(2). 486–492. 3 indexed citations
9.
10.
Cipolla, B., Jean‐Yves Bansard, Jacques-Philippe Moulinoux, et al.. (1996). Pretherapeutic erythrocyte polyamine spermine levels discriminate high risk relapsing patients with M1 prostate carcinoma. Cancer. 78(5). 1055–1065. 27 indexed citations
11.
Huerre, M, et al.. (1996). A Case of Myospherulosis Occurring in the Perirenal Adipose Tissue. Pathology - Research and Practice. 192(2). 172–178. 9 indexed citations
12.
Staerman, F., et al.. (1996). [Dose adaptation during training of intracavernous self-injections of prostaglandin E1].. PubMed. 6(4). 564–8. 1 indexed citations
13.
Seiler, Nikolaus, et al.. (1996). Observations with an S-adenosylmethionine decarboxylase inhibitor in rats with prostatic adenocarcinoma.. PubMed. 46(3). 311–5. 3 indexed citations
14.
15.
Staerman, F., et al.. (1995). [Testicular microlithiasis: ultrasonographic diagnosis and semiologic value].. PubMed. 5(5). 717–9. 1 indexed citations
16.
Corbel, L., et al.. (1994). [Acquired experience in anesthesia and perioperative intensive care in percutaneous nephrolithotomy. Current approach in the endoscopic treatment of lithiasis and pyelo-ureteral junction anomalies].. PubMed. 4(1). 56–62. 2 indexed citations
17.
Cipolla, B., F. Guillé, V. Quémener, et al.. (1993). Polyamines and ProstaticCarcinoma: Clinical andTherapeutic Implications. European Urology. 24(1). 124–131. 27 indexed citations
18.
Guillé, F., et al.. (1991). Early Endoscopic Realignment of Complete Traumatic Rupture of the Posterior Urethra. British Journal of Urology. 68(2). 178–180. 28 indexed citations
19.
Cipolla, B., F. Guillé, R Havouis, et al.. (1991). The Growth of MAT-LyLu Rat Prostatic Adenocarcinoma can be Prevented in Vivo by Polyamine Deprivation. The Journal of Urology. 146(5). 1408–1412. 23 indexed citations
20.
Cipolla, B., et al.. (1990). Erythrocyte Polyamine Levels in Human Prostatic Carcinoma. The Journal of Urology. 144(5). 1164–1166. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026